Home Healthcare Pharmaceuticals Insulin Market

Insulin Market Size, Share & Trends Analysis Report By Type (Human Insulin, Analog Insulin), By Product (Short-Acting Insulin, Intermediate Acting Insulin, Long-Acting Insulin, Fast-Acting Insulin), By Applications (Type I Diabetes, Type II Diabetes, Gestational Diabetes, Pre-diabetes), By Distribution Channel (Hospitals, Drug Stores & Retail Pharmacies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 30, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Insulin Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Human Insulin
    2. Analog Insulin
  2. Insulin Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Short-Acting Insulin
    2. Intermediate Acting Insulin
    3. Long-Acting Insulin
    4. Fast-Acting Insulin
  3. Insulin Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Type I Diabetes
    2. Type II Diabetes
    3. Gestational Diabetes
    4. Pre-diabetes
  4. Insulin Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Drug Stores & Retail Pharmacies
    3. Others
  5. Regional Insulin Market
    1. North America
      1. North America Insulin Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human Insulin
        2. Analog Insulin
      2. North America Insulin Market By Product 2022-2034 (USD MILLION/ Units)
        1. Short-Acting Insulin
        2. Intermediate Acting Insulin
        3. Long-Acting Insulin
        4. Fast-Acting Insulin
      3. North America Insulin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Type I Diabetes
        2. Type II Diabetes
        3. Gestational Diabetes
        4. Pre-diabetes
      4. North America Insulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug Stores & Retail Pharmacies
        3. Others
      5. U.S.
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      6. Canada
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
    2. Europe
      1. Europe Insulin Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human Insulin
        2. Analog Insulin
      2. Europe Insulin Market By Product 2022-2034 (USD MILLION/ Units)
        1. Short-Acting Insulin
        2. Intermediate Acting Insulin
        3. Long-Acting Insulin
        4. Fast-Acting Insulin
      3. Europe Insulin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Type I Diabetes
        2. Type II Diabetes
        3. Gestational Diabetes
        4. Pre-diabetes
      4. Europe Insulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug Stores & Retail Pharmacies
        3. Others
      5. U.K.
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      6. Germany
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      7. France
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      8. Spain
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      9. Italy
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      10. Russia
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      11. Nordic
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      12. Benelux
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      13. Rest of Europe
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
    3. APAC
      1. APAC Insulin Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human Insulin
        2. Analog Insulin
      2. APAC Insulin Market By Product 2022-2034 (USD MILLION/ Units)
        1. Short-Acting Insulin
        2. Intermediate Acting Insulin
        3. Long-Acting Insulin
        4. Fast-Acting Insulin
      3. APAC Insulin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Type I Diabetes
        2. Type II Diabetes
        3. Gestational Diabetes
        4. Pre-diabetes
      4. APAC Insulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug Stores & Retail Pharmacies
        3. Others
      5. China
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      6. Korea
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      7. Japan
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      8. India
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      9. Australia
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      10. Singapore
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      11. Taiwan
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      12. South East Asia
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      13. Rest of Asia-Pacific
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
    4. Middle East and Africa
      1. Middle East and Africa Insulin Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human Insulin
        2. Analog Insulin
      2. Middle East and Africa Insulin Market By Product 2022-2034 (USD MILLION/ Units)
        1. Short-Acting Insulin
        2. Intermediate Acting Insulin
        3. Long-Acting Insulin
        4. Fast-Acting Insulin
      3. Middle East and Africa Insulin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Type I Diabetes
        2. Type II Diabetes
        3. Gestational Diabetes
        4. Pre-diabetes
      4. Middle East and Africa Insulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug Stores & Retail Pharmacies
        3. Others
      5. UAE
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      6. Turkey
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      7. Saudi Arabia
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      8. South Africa
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      9. Egypt
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      10. Nigeria
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      11. Rest of MEA
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
    5. LATAM
      1. LATAM Insulin Market By Type 2022-2034 (USD MILLION/ Units)
        1. Human Insulin
        2. Analog Insulin
      2. LATAM Insulin Market By Product 2022-2034 (USD MILLION/ Units)
        1. Short-Acting Insulin
        2. Intermediate Acting Insulin
        3. Long-Acting Insulin
        4. Fast-Acting Insulin
      3. LATAM Insulin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Type I Diabetes
        2. Type II Diabetes
        3. Gestational Diabetes
        4. Pre-diabetes
      4. LATAM Insulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Drug Stores & Retail Pharmacies
        3. Others
      5. Brazil
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      6. Mexico
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      7. Argentina
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      8. Chile
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      9. Colombia
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
      10. Rest of LATAM
        1. Human Insulin
        2. Analog Insulin
        3. Short-Acting Insulin
        4. Intermediate Acting Insulin
        5. Long-Acting Insulin
        6. Fast-Acting Insulin
        7. Type I Diabetes
        8. Type II Diabetes
        9. Gestational Diabetes
        10. Pre-diabetes
        11. Hospitals
        12. Drug Stores & Retail Pharmacies
        13. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.